Kansas

The Board of Pharmacy announced that the Collaborative Drug Therapy Management Committee adopted several protocols for testing and initiation of therapy for:
– Suspected Influenza in Adult Patients
– Suspected Influenza in Patients under 18 years of age
– Suspected Acute Group A Streptococcal Pharyngitis in Adult Patients
– Suspected Acute Group A Streptococcal Pharyngitis in Patients under 18 years of age
– Suspected Acute Uncomplicated Lower Urinary Tract Infection in Women

Also in Kansas, the Board of Pharmacy approved a new emergency opioid antagonist (EOA) protocol adding an opioid antagonist drug ready-to-use nasal spray device to the drugs that may be dispensed.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-10-06T10:03:50-04:00October 6, 2023|Kansas|

Kentucky

It is NACDS’ understanding that pharmacy claims for the updated Pfizer-BioNTech and Moderna COVID-19 vaccines have been rejecting under the pharmacy benefit through MedImpact. The Kentucky Pharmacy Association shared with us that Medicaid has decided to cover the new vaccines under the pharmacy benefit. MedImpact is working on system edits to accommodate pharmacy billing and will notify pharmacies when it is implemented. Additionally, managed care coverage will begin for the Abrysvo (Pfizer) and Arexvy (GSK) RSV vaccines effective October 6. For more information on Medicaid vaccine coverage, please see the updated version of MedImpact’s Vaccine Coverage Expansion.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-10-06T10:03:05-04:00October 6, 2023|Kentucky|

Louisiana

Effective October 1, 2023, the Department of Health (LHD) is increasing the professional dispensing fee (PDF) $0.82 to $11.81 for local pharmacies only for all Medicaid Fee-for-Service (FFS) and Managed Care Organization (MCO)claims. The current PDF is $10.99.

Also in Louisiana, the Department of Health (LDH) Bureau of Health Services Financing’s Interim Medicaid Executive Director Kimberly Sullivan announced the new implementation date for the Single Pharmacy Benefits Manager (PBM) for Managed Care Organizations (MCOs) is now October 28, 2023. Magellan Medicaid Administration Inc. will serve as the single PBM processor for all six MCOs (Aetna, AmeriHealth Caritas, Healthy Blue, Humana Healthy Horizons, Louisiana Healthcare Connections and United Healthcare).

Also in Louisiana, the Board published five final rules in the September 20, 2023, edition of the Louisiana Register, with immediate effective dates.

Finally in Louisiana, the Department of Health (LDH) Medicaid issued several documents detailing changes also effective October 1:

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-10-06T10:02:30-04:00October 6, 2023|Louisiana|

Maryland

Medicaid has issued Advisory #251 from the Office of Pharmacy Services in reference to the COVID-19 Home Test Kit Coverage for The Maryland Medicaid Fee-for-Service (FFS) Program. Anyone interested in directly receiving upcoming Advisories may forward his/her name, company affiliation and email address directly to: Deborah.washington@maryland.gov.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-10-06T10:01:36-04:00October 6, 2023|Maryland|

Michigan

The Board of Pharmacy has posted the public notice and agenda for the October 30 Rules Committee Work Group meeting and the minutes from the September 11 Rules Committee Work Group meeting.

Also in Michigan, MDHHS (Michigan Department of Health and Human Services) has proposed a rule regarding documenting patient consent for automatic refills that aligns with 2014 CMS guidance. Comments are due November 7 to the email noted on the policy’s transmittal sheet.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-10-06T10:00:42-04:00October 6, 2023|Michigan|

Missouri

On September 28, the Board of Pharmacy issued a statement on working conditions recommending that pharmacies review current operations and address any issues that may impede safe patient care, including pharmacy staffing and any metrics/quotas that may hinder safe patient services. The Board also recommends pharmacies provide any additional resources or protections needed to minimize any job-related stressors of pharmacy personnel.

Also in Missouri, the Board of Pharmacy posted the September newsletter which includes detailed information on pharmacists’ new immunization authority, and the recently revised statewide naloxone standing order.

Also in Missouri, the state’s Department of Social Services Division of Health published rules in the State Register (p13-15) establishing a Pharmacy Federal Reimbursement Allowance and methodologies to determine the formula for the amount of allowance each pharmacy is required to pay for the privilege of providing outpatient prescription drugs.

Finally in Missouri, the Department of Health and Senior Services’ Division of Regulation and Licensure issued an emergency regulation on Controlled Substances.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-10-06T09:59:48-04:00October 6, 2023|Missouri|

Ohio

The Senate Health Committee will hold a proponent hearing on SB 144, sponsored by Sen. Mark Romanchuk (R), on October 11 at 9:30 a.m. The legislation would authorize pharmacists and pharmacy technicians to administer routine childhood vaccines to patients 5 years of age and older and remove the prescription requirement for these vaccines. The Ohio Council of Retail Merchants and the Ohio Pharmacists Association will be testifying and NACDS will submit written testimony in support. Testimony and letters of support are due at 9:30 a.m. on October 10. If any members wish to weigh in, either in person or with written testimony, please contact Jill McCormack for further details.

Also in Ohio, the Board of Pharmacy has issued a lengthy agenda for the October 24 public hearing.

Finally in Ohio, the Board of Pharmacy has posted Proposed Compounding Rules related to USP 795 and 797. Comments are due October 24.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-10-06T09:58:51-04:00October 6, 2023|Ohio|

Oklahoma

Gov. Kevin Stitt (R) convened a special session of the legislature on October 3 to address tax reforms.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-10-06T09:57:56-04:00October 6, 2023|Oklahoma|

New York

Effective September 11, 2023, the State Department of Health’s NYRx, the Medicaid Pharmacy Fee-For-Service program, will provide reimbursement for qualified and enrolled pharmacies for COVID-19 vaccines and administration as approved by the FDA or authorized for emergency use. Billing codes and other guidance provided in the announcement.

Also in New York, on September 12, the State Education Department withdrew the proposed central fill pharmacy regulations. The Department and the Board of Pharmacy will convene stakeholders and restart the regulatory process. NACDS and members had been actively advocating for a change and delay in the proposed regulations, that amongst its provisions would have created a new central fill pharmacy registration class, prohibited central fill pharmacies from being open to the public, require that central fill pharmacies only prepare and fill prescriptions sent from an originating pharmacy, prohibited direct-to-patient central fill models and required the originating pharmacy to obtain consent from the patient in writing before a prescription may be prepared by a central fill pharmacy. A broad coalition of pharmacy interests are unified in opposition and pushed for support for delayed consideration. NACDS also previously submitted a letter during the public comment period.

Also in New York, on September 20, the State Department of Health held its monthly industry call for NYRx, the Medicaid fee-for-service program. The Education and Outreach team for NYRx holds virtual office hours on Tuesdays and Thursdays from 12:00 noon to 1:00 p.m. Eastern.

Finally in New York, on September 22, the State Department of Health, on behalf of NYRx, relayed to pharmacies that Medicaid patients are prohibited from paying out of pocket for covered services. The COVID vaccine is covered, and no Medicaid recipient should be asked to pay. The Department noticed that some Medicaid members were mistakenly informed that the vaccine was not covered and may have paid out of pocket. These claims should be promptly resubmitted, and the member contacted and reimbursed for all out-of-pocket costs. The State Department of Health has posted the “Medicaid Coverage Policy and Billing Guidance for the Administration of COVID-19 Vaccines.”

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-10-06T09:56:59-04:00October 6, 2023|New York|
Go to Top